期刊文献+

阿霉素肾病小鼠的肾脏病理转变过程 被引量:12

Pathological changes of the kidneys in mouse models of adriamycin-induced-nephrosis
下载PDF
导出
摘要 目的观察不同时间点阿霉素肾病小鼠肾脏病理的转变过程。方法 48只雄性BALB/c小鼠,随机分成对照组和模型组,模型组经尾静脉一次性注射阿霉素10.5mg/kg,对照组给予等量的生理盐水。动态观察实验12周内小鼠24 h尿蛋白、血清生化指标、肾脏病理改变。结果模型小鼠蛋白尿于实验第2周出现,持续至第12周,第8周出现高峰(均P<0.05);低蛋白血症、高脂血症分别于实验第4、8周出现,血肌酐于实验第12周明显高于正常组(均P<0.05)。模型小鼠肾脏病理改变第4周表现为微小病变型;第8周病变较第4周加重,硬化不明显;第12周出现肾小球局灶节段性硬化、肾小球硬化指数(GSI)为(2.81±0.84)%,明显高于同一观测时间点对照组GSI(0.33±0.21)%(P<0.01)。结论一次性尾静脉注射10.5 mg/kg阿霉素,能成功复制阿霉素肾病小鼠模型,该模型在早期表现为微小病变型肾病,晚期转变为局灶性节段性肾小球硬化。 Objective Our purpose was to observe the renal pathological changes in the mouse modells of adriamy -cin-induced nephropathy in different periods .Method 48 healthy male BALB/c mice were randomly divided into control group and model group .The model group received a disposable tail vein injection of adriamycin 10.5 mg/kg body weight , and the control group received the same amount of saline .24-hour urinary protein , serum biochemical indexes and kidney pathological changes were dynamically observed for 12 weeks.Results Proteinuria of model mice appeared in the 2th week after ADR injection, which lasted to the end of the 12-week experiment, At the 8th week, the amount of urine protein reached a peak (P〈0.05);The serum albumin was decreased at the 4th week, cholesterol was increased at 8th week.At the end of experiment, serum creatinine was also increased (P〈0.05).Minimal change nephrotic syndrome (MCNS) was observed in model mice at the 4th week;the lesions in renal tissues at 8th weeks were more serious than that at 4th weeks, but glomerular sclerosis was unconspicuous .Focal segmental glomerulonephritis ( FSGS) was seen at the 12th week.The GSI of the model mice was(2.81 ±0.84)%, significantly higher than that of the control mice ((0.33 ±0.21)%) at 12th&amp;nbsp;week(P〈0.01).Conclusions A mouse model with adriamycin-induced-nephrosis can be successfully established by a disposable tail vein injection of adriamycin in a dose of 10.5 mg/kg body weight .The early manifest ation of this model is MCNS, and at a late stage , it may be changed into FSGS .
出处 《中国实验动物学报》 CAS CSCD 2014年第2期13-16,I0002,共5页 Acta Laboratorium Animalis Scientia Sinica
基金 国家自然科学基金资助青年项目(No.81100506)和国家自然科学基金资助面上项目(No.81270802)
关键词 阿霉素肾病 小鼠 肾脏 Adriamycin nephropathy Mice Kidney
  • 相关文献

参考文献15

  • 1Okuda S,Oh Y,Tsuruda H,et al.Adriamycin-induced ne-phropathy as a model of chronic progressive glomerular disease [J].Kidney Int.1986,29(2):502-510.
  • 2Watanabe Y,Itoh Y,Yoshida F,et al.Unique glomerular lesion with spontaneous lipid deposition in glomerular capillary lumina in the NON strain of mice [J].Nephron.1991,58(2):210-218.
  • 3Chen A,Sheu LF,Ho YS,et al.Experimental focal segmental glomerulosclerosis in mice [J].Nephron.1998,78(4):440-452.
  • 4Rodriguez-Iturbe B,Quiroz Y,Shahkarami A.Mycophenolate mofetil ameliorates nephropathy in the obese Zucker rat [J].Kidney Int.2005,68(3):1041-1047.
  • 5杨维娜,于琳华,钱亦华,靳辉,郑黎明,柴云.阿霉素肾病大鼠模型动态变化及其足细胞数量和nephrin的表达变化[J].中山大学学报(医学科学版),2009,30(5):512-516. 被引量:13
  • 6张勇,张蓓,宁华英,郭云良,邢广群,沈卫.单次尾静脉注射法阿霉素大鼠肾病模型的建立[J].中国实验动物学报,2013,21(1):1-4. 被引量:25
  • 7孙艳萍,陈金和,陈贤钧.丹参对大鼠肾脏近曲小管超微结构保护机制的研究[J].中国中西医结合肾病杂志,2003,4(3):145-147. 被引量:25
  • 8Simic I,Mansoureh Tabatabaeifar M,Schaefer F.Animal mod-els of nephrotic syndrome [J].Pediatr Nephrol 2013,8:2079-2088.
  • 9Hu P,Qin YH,Lu L,et al.Genetic variation of apolipoprotein E does not contribute to the lipid abnormalities secondary to childhood minimal change nephrotie syndrome [J].Int Urol Nephrol.2010,42(2):453-460.
  • 10L Cagnoli.Instructions and implementations for pereutaneous re-nal biopsy.Guidelines for the therapy of glomerular nephropaties [J].Italian Soe Nephrologyl.2003,20(24):$3-47.

二级参考文献92

  • 1张丽芬,黄文政,朱小棣,王耀光.阿霉素肾病肾小球硬化动物模型的研究[J].中国中西医结合肾病杂志,2005,6(4):195-199. 被引量:55
  • 2丁跃玲,丁英钧,赵玉庸.阿霉素肾病大鼠α-SMA表达特点及缬沙坦的干预治疗[J].中国药理学通报,2005,21(6):730-733. 被引量:6
  • 3赵宗江,仇琪,杨美娟.海昆肾喜对阿霉素肾病大鼠肾组织结缔组织生长因子蛋白及其mRNA表达的影响[J].中国中西医结合肾病杂志,2006,7(12):689-692. 被引量:19
  • 4Dusel JA, Burdon KP, Hicks PJ, et al. Identification of podocin ( NPHS2 ) gene mutations in African Americans with nondiabetic end - stage renal disease [ J ]. Kidney Int,2005,68 ( 1 ) :256 - 262.
  • 5Franceschini N,North KE, Kopp JB,et al. NPHS2 gene, nephrotie syndrome and focal segmental glomeruloselerosis : A HuGE review [ J ]. Genet Med,2006,8(2) :63 -75.
  • 6Philippe A, Weber S, Esquivel EL, et al. A missense mutation in podocin leads to early and severe renal disease in mice[ J]. Kidney Int ,2008,73 (9) :1038 - 1047.
  • 7Berdeli A, Mir S, Yavascan O, et al. NPHS2 (podiein) mutations in Turkish children with idiopathic nephrotic syndrome [ J ]. Pediatr Nephrol,2007,22 ( 12 ) :2031 - 2040.
  • 8McKenzie LM, Hendrickson SL, Briggs WA, et al. NPHS2 variation in sporadic focal segmental glomerulosclerosis [ J ]. J Am Soc Nephrol, 2007,18 ( 11 ) :2987 - 2995.
  • 9Niaudet P, Gubler MC. WT1 and glomerular diseases[ J ]. Pediatr Nephrol,2006,21 ( 11 ) : 1653 - 1660.
  • 10Mucha B,Ozaltin F,Hinkes BG,et al. Mutations in the Wilms' tumor 1 gene cause isolated steroid resistant nephrotic syndrome and occur in exons 8 and 9[J] Pediatr Res ,2006,59(2) :325 -331.

共引文献103

同被引文献113

引证文献12

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部